Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
Read moreLos resultados del estudio GARNET, liderado por Vall d’Hebron, abren la puerta a una nueva terapia para pacientes con cáncer de endometrio avanzado con deficiencia en el sistema de reparación de e...
Read more Gene therapies currently under study for retinal dystrophies are administered when viable photoreceptor able to be rescued at the functional level still remain. Most therapies are gene-specific...
Read moreFreeOx Biotech, a CataloniaBio & HealthTech member, has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use o...
Read moreCNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack
Read moreImmuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital Clínic de Barcelona (HCB) and Institut d’...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...
Read moreAmerican Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...
Read moreEl mundo trabaja a contrarreloj para conseguir un tratamiento contra la Covid-19. Y las células madre son una de las alternativas en las que los investigadores están poniendo el foco. Actualmente es...
Read moreEl estudio Solidarity, coordinado por la Organización Mundial de la Salud en más de 30 países, indica que las terapias con remdesivir, hidroxicloroquina, lopinavir/ritonavir e interferón no han te...
Read moreSOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020.
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, celebrated yest...
Read more